On Episode 304 of The Core Report, financial journalist Govindraj Ethiraj talks to London-based Arvind Chari, chief investment officer, Q India (UK) Ltd as well as Dr Viranchi Shah, national president of the Indian Drug Manufacturers Association (IDMA).
SHOW NOTES
- (00:00) Stories Of The Day
- (01:09) Investors are increasing long positions ahead of Election Results
- (04:50) Foreign investors are looking at Indian debt differently from equity right now and amping up investments
- (14:39) Indian drug makers have a strong year ahead with increase imports from countries like United States
- (25:06) Toyota sticks to hybrid bet
- (27:18) Weight loss drug sales projected to go from $24 billion last year to $138 billion in 2028 or in four years time
For more of our coverage check out thecore.in
--Support the Core Report--
Join and Interact anonymously on our whatsapp channel
Subscribe to our Newsletter
Follow us on:
Twitter | Instagram | Facebook | Linkedin | Youtube
